A public health concern — that’s how experts describe a new study that finds the FDA is way behind on critical inspections of factories that make everything from antibiotics to cancer therapies.
A public health concern — that’s how experts describe a new study that finds the FDA is way behind on critical inspections of factories that make everything from antibiotics to cancer therapies.
